EINSCHLUSSKOMPLEXE DES 3-MORPHOLINO-SYDNONIMINS ODER SEINE SALZE ODER SEINE ISOMEREN TAUTOMERE, VERFAHREN ZUR HERSTELLUNG DIESER KOMPLEXE UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DIE DIESE KOMPLEXE ENTHALTEN

PCT No. PCT/HU91/00013 Sec. 371 Date Jan. 2, 1992 Sec. 102(e) Date Jan. 2, 1992 PCT Filed Mar. 28, 1991.The invention relates to inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the sam...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VIKMON, MARIA, H-1026 BUDAPEST, HU, SZEJTLI, JOZSEF, H-1026 BUDAPEST, HU, HERMECZ, ISTVAN, H-1056 BUDAPEST, HU, GAAL, JOZSEF, H-1174 BUDAPEST, HU, MARMAROSI, KATALIN, H-2051 BIATORBAGY, HU, MUNKACSI, IREN, H-1084 BUDAPEST, HU, HORVATH, AGNES, H-1021 BUDAPEST, HU, HORVATH, GABOR, H-1133 BUDAPEST, HU, SZENTE, LAJOS, H-1033 BUDAPEST, HU
Format:	Patent
Sprache:	ger
Schlagworte:	CHEMISTRY COMPOSITIONS BASED THEREON DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY ORGANIC MACROMOLECULAR COMPOUNDS POLYSACCHARIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR PREPARATION OR CHEMICAL WORKING-UP
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PCT No. PCT/HU91/00013 Sec. 371 Date Jan. 2, 1992 Sec. 102(e) Date Jan. 2, 1992 PCT Filed Mar. 28, 1991.The invention relates to inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same. The inclusion complex of 3-morpholino-sydnonimine or its salt formed with cyclodextrin derivative is prepared by a) reacting the 3-morpholino-sydnonimine or its salt in an aqueous medium with a cyclodextrin derivative and the complex is isolated from the solution by dehydratation, or b) high energy milling of 3-morpholino-sydnonimine or its salt and a cyclodextrin derivative.